{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:43:56Z","timestamp":1757699036467},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/md.0000000000003842","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T05:13:57Z","timestamp":1466054037000},"page":"e3842","source":"Crossref","is-referenced-by-count":3,"title":["Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients"],"prefix":"10.1097","volume":"95","author":[{"given":"Lola","family":"Falcon-Neyra","sequence":"first","affiliation":[]},{"given":"Claudia","family":"Palladino","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[]},{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda Isabel","family":"Gonz\u00e1lez-Tom\u00e9","sequence":"additional","affiliation":[]},{"given":"Santiago J.","family":"De Ory","sequence":"additional","affiliation":[]},{"given":"Marie Antoinette","family":"Frick","sequence":"additional","affiliation":[]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[]},{"given":"Elena Berm\u00fadez","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Juan Luis","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Olbrich","sequence":"additional","affiliation":[]},{"given":"Luis F.","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[]},{"given":"Ver\u00f3nica","family":"Briz","sequence":"additional","affiliation":[]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-21-20211111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archpedi.157.3.249","article-title":"Barriers to HAART adherence among human immunodeficiency virus-infected adolescents","volume":"157","author":"Murphy","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R2-21-20211111","first-page":"14","article-title":"A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth","volume":"17","author":"Reisner","year":"2009","journal-title":"Top HIV Med"},{"key":"R3-21-20211111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11587300-000000000-00000","article-title":"Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges","volume":"13","author":"Phelps","year":"2011","journal-title":"Paediatr Drugs"},{"key":"R4-21-20211111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.332.7551.1183","article-title":"Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997\u20132005: cohort study","volume":"332","author":"Menson","year":"2006","journal-title":"BMJ"},{"key":"R5-21-20211111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"R6-21-20211111","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/pr.110.003533","article-title":"Pharmacogenetics, pharmacogenomics, and individualized medicine","volume":"63","author":"Ma","year":"2011","journal-title":"Pharmacol Rev"},{"key":"R7-21-20211111","first-page":"115","article-title":"One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects","volume":"13","author":"Airoldi","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"R8-21-20211111","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.7448\/IAS.15.6.18098","article-title":"Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study","volume":"15","author":"Antinori","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"R9-21-20211111","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","article-title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","volume":"378","author":"Molina","year":"2011","journal-title":"Lancet"},{"key":"R10-21-20211111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)60983-5","article-title":"Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial","volume":"378","author":"Cohen","year":"2011","journal-title":"Lancet"},{"key":"R11-21-20211111","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/QAD.0000000000000169","article-title":"Week 48 results from a randomized clinical trial of rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate vs. efavirenz\/emtricitabine\/tenofovir disoproxil fumarate in treatment-na\u00efve HIV-1-infected adults","volume":"28","author":"Cohen","year":"2014","journal-title":"AIDS"},{"key":"R12-21-20211111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0000000000000087","article-title":"Simplification to rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants","volume":"28","author":"Palella","year":"2014","journal-title":"AIDS"},{"key":"R16-21-20211111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-13-2","article-title":"A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)","volume":"13","author":"de Jose","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R19-21-20211111","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Top Antivir Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201606140-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T20:03:18Z","timestamp":1636660998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201606140-00021"}},"subtitle":["A multicenter study"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":14,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003842","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}